Home › Funds › Citigroup Inc › TRDA

Citigroup Inc position in TRDA

ENTRADA THERAPEUTICS INC · Health Care

Latest position (Q2 2026)14.79K sh
Reported value held$108.85K
Portfolio Weight0.00%
First reportedQ4 2021
Last changeAdd

Quarter by quarter

QuarterSharesValueChange
Q4 2021 2.39K $41.00K New
Q1 2022 413 $4.00K Reduce
Q2 2022 94 $1.00K Reduce
Q3 2022 1.58K $25.00K Add
Q4 2022 51.04K $690.09K Add
Q1 2023 62.02K $899.33K Add
Q2 2023 6.66K $100.88K Reduce
Q3 2023 31 $490 Reduce
Q4 2023 3.11K $46.93K Add
Q1 2024 56.29K $797.59K Add
Q2 2024 5.54K $78.99K Reduce
Q3 2024 17.98K $287.35K Add
Q4 2024 19.88K $343.69K Add
Q1 2025 18.59K $168.02K Reduce
Q2 2025 13.41K $90.09K Reduce
Q3 2025 2.05K $11.88K Reduce
Q4 2025 4.12K $42.39K Add
Q1 2026 4.85K $61.24K Add
Q2 2026 14.79K $108.85K Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

Other funds holding TRDA

All TRDA fund holders →